A Study to Evaluate Enfortumab Vedotin in Subjects With Locally Advanced or Metastatic Malignant Solid Tumors (EV-202)
Astellas Pharma Inc
Astellas Pharma Inc
Janssen Pharmaceutical K.K.
GlaxoSmithKline
Jazz Pharmaceuticals
IO Biotech
Seagen Inc.
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Seagen Inc.
Regeneron Pharmaceuticals
Incyte Corporation
AstraZeneca
Regeneron Pharmaceuticals
Seagen Inc.
Fulgent Pharma LLC.
VSPharmTech Co.,Ltd.
Hoffmann-La Roche
Endeavor Biomedicines, Inc.
Gilead Sciences
Daiichi Sankyo
MacroGenics
Shanghai Miracogen Inc.
DualityBio Inc.
Flamingo Therapeutics NV
Daiichi Sankyo
CSPC Megalith Biopharmaceutical Co.,Ltd.
Sichuan Baili Pharmaceutical Co., Ltd.
Sichuan Baili Pharmaceutical Co., Ltd.
Aveta Biomics, Inc.
Shanghai Institute Of Biological Products
ImmunityBio, Inc.
I-Mab Biopharma US Limited
Immutep S.A.S.
Regeneron Pharmaceuticals
Merck Sharp & Dohme LLC
MediLink Therapeutics (Suzhou) Co., Ltd.
Pfizer
Shanghai Henlius Biotech
Gilead Sciences
Bayer
Merck Sharp & Dohme LLC
Tempus AI
BeiGene
Day One Biopharmaceuticals, Inc.
PDS Biotechnology Corp.
Hoffmann-La Roche
Sichuan Baili Pharmaceutical Co., Ltd.
Sichuan Baili Pharmaceutical Co., Ltd.
BioAtla, Inc.
Sichuan Baili Pharmaceutical Co., Ltd.
Sichuan Baili Pharmaceutical Co., Ltd.